We are proud to share that the ALL WOMEN study has successfully reached its enrollment goal, and patient inclusion is now completed.
Thank you to everyone involved for your strong commitment and teamwork.
The next focus is data completion for primary endpoint communications.
Learn more about the ALL WOMEN study here
Study sponsored by Ceric, with the support of Biosensors.
CERC. Smart trials. Strong results.
